Dow Up1.53% Nasdaq Up1.70%

GW Pharmaceuticals plc (GWPH)

-NasdaqGM
73.33 Up 1.63(2.27%) 12:35PM EDT - Nasdaq Real Time Price
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingSep 30, 2013Sep 30, 2012Sep 30, 2011
Total Revenue 44,202   53,482   46,153  
Cost of Revenue2,066  1,355  2,098  
Gross Profit 42,135   52,128   44,055  
Operating Expenses
Research Development52,950  44,533  35,384  
Selling General and Administrative6,141  5,910  5,138  
Non Recurring -   -   -  
Others -   -   -  
Total Operating Expenses -   -   -  
Operating Income or Loss (16,955) 1,684   3,533  
Income from Continuing Operations
Total Other Income/Expenses Net288  323  410  
Earnings Before Interest And Taxes(16,667)2,008  3,943  
Interest Expense104  2  5  
Income Before Tax(16,771)2,006  3,938  
Income Tax Expense(9,404)(2,015)(344)
Minority Interest -   -   -  
Net Income From Continuing Ops(7,367)4,021  4,282  
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income (7,367) 4,021   4,282  
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares (7,367) 4,021   4,282  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.